SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 39 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,013,803 | -39.5% | 601,000 | -39.8% | 0.00% | – |
| Q3 2022 | $1,676,000 | +32.5% | 998,000 | -0.3% | 0.00% | – |
| Q2 2022 | $1,265,000 | +181.1% | 1,001,000 | +226.1% | 0.00% | – |
| Q4 2021 | $450,000 | -11.9% | 307,000 | -10.5% | 0.00% | – |
| Q3 2021 | $511,000 | -80.0% | 343,000 | -82.5% | 0.00% | – |
| Q1 2021 | $2,557,000 | +52.8% | 1,957,000 | +185.7% | 0.00% | – |
| Q4 2020 | $1,673,000 | +50.4% | 685,000 | +28.0% | 0.00% | – |
| Q3 2020 | $1,112,000 | +130.2% | 535,000 | +154.8% | 0.00% | – |
| Q2 2020 | $483,000 | -66.4% | 210,000 | -78.3% | 0.00% | – |
| Q1 2020 | $1,436,000 | -86.6% | 968,000 | -82.4% | 0.00% | -100.0% |
| Q4 2019 | $10,703,000 | +1521.7% | 5,504,000 | +1000.8% | 0.00% | – |
| Q3 2019 | $660,000 | +242.0% | 500,000 | +405.1% | 0.00% | – |
| Q2 2019 | $193,000 | -71.1% | 99,000 | -73.6% | 0.00% | – |
| Q1 2019 | $667,000 | – | 375,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 53,865,000 | $101,127,280 | 3.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,657,000 | $165,397,613 | 3.42% |
| Boussard & Gavaudan Investment Management LLP | 11,898 | $21,871,538 | 2.42% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,394,000 | $71,834,226 | 1.71% |
| WOLVERINE ASSET MANAGEMENT LLC | 79,876,000 | $149,367,384 | 1.55% |
| CSS LLC/IL | 4,747,000 | $8,868,606 | 0.50% |
| Opti Capital Management, LP | 3,000,000 | $5,611,938 | 0.48% |
| Verition Fund Management LLC | 16,459,000 | $30,786,560 | 0.48% |
| Aequim Alternative Investments LP | 5,000,000 | $9,352,500 | 0.25% |
| MIZUHO SECURITIES USA LLC | 1,097,000 | $2,047,616 | 0.19% |